Meitav Investment House’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Meitav Investment House’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,466	Closed	-$2.49M	–	468
2019 Q4	$2.49M	Sell	8,466 -1,076	-11%	-$217K	0.18%	67
2019 Q3	$1.75M	Sell	9,542 -2,969	-24%	-$845K	0.13%	96
2019 Q2	$4.99M	Hold	12,511	–	–	0.33%	53
2019 Q1	$5.84M	Sell	12,511 -403	-3%	-$196K	0.33%	54
2018 Q4	$6.2M	Sell	12,914 -498	-4%	-$275K	0.38%	62
2018 Q3	$9.12M	Hold	13,412	–	–	0.44%	56
2018 Q2	$7.86M	Buy	+13,412	New	+$8.69M	0.35%	68

Other funds holding ELOX

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Meitav Investment House's ELOX Position: Q1 2020 in Review

Meitav Investment House sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2020, closing a stake of 8,466 shares — an estimated $2.49M sold.

Meitav Investment House first reported a position in ELOX in Q2 2018 and held it in 7 quarters. The position peaked at $9.12M in Q3 2018. 43 funds tracked by Wall St. Rank hold ELOX as of Q1 2020.

Meitav Investment House reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Meitav Investment House sold 8,466 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $2.49M.
Meitav Investment House first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 7 quarters.
Meitav Investment House's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $9.12M in Q3 2018.
43 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Meitav Investment House's 13F filing for Q1 2020, filed 11 May 2020.